The FDA has approved Novartis' drug Rhapsido for treating symptomatic dermographism, offering a new solution for adults suffering from chronic hives and itchy welts. This significant approval ...
Granules India Ltd plans to invest ₹2,000 crore over 3-4 years to enhance its pharmaceuticals business, focusing on complex ...
Researchers harness AI to develop mRNA vaccines that can be stored at room temperature, drastically reducing costs and ...
Danaher, a leader in life sciences, announces its groundbreaking AI-powered autonomous research lab aimed at accelerating ...
AI firms are increasingly conducting virtual drug trials to predict the success of human studies, enhancing the likelihood that experimental medicines are effective and safe.
Small and mid-sized Indian pharmaceutical firms are witnessing a shift in orders from China to India due to cost and quality ...
The Gujarat-based company, which began as an agrochemicals supplier, has grown its pharma business from almost nil to about ...
AstraZeneca secures approval for camizestrant (Etcamah), an innovative breast cancer drug in India, promising an advanced ...
Opinion
The Molecule and the Machine: How Artificial Intelligence Is Rewiring Biopharma From Gene to Patient
Artificial Intelligence is transforming the biopharmaceutical industry by accelerating drug discovery, enhancing personalized medicine, and making clinical trials more efficient, promising to bring ...
Eris Lifesciences appoints Chirag Mehta as Executive Director, overseeing international business, finance, and investor ...
Aragen Life Sciences has unveiled Aragen OneHP, an integrated platform for developing and manufacturing peptides and antibody ...
G, a new fixed-dose combination inhaler for the effective management of chronic obstructive pulmonary disease (COPD) in India ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results